Cargando…
Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones
Mutations in the dopamine transporter gene (SLC6A3) have been implicated in many human diseases. Among these is the infantile parkinsonism-dystonia known as Dopamine Transporter Deficiency Syndrome (DTDS). Afflicted individuals have minimal to no functional dopamine transporter protein. This is prim...
Autores principales: | Sutton, Charles, Williams, Erin Q., Homsi, Hoomam, Beerepoot, Pieter, Nazari, Reza, Han, Dong, Ramsey, Amy J., Mash, Deborah C., Olson, David E., Blough, Bruce, Salahpour, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124866/ https://www.ncbi.nlm.nih.gov/pubmed/35614973 http://dx.doi.org/10.3389/fncel.2022.832536 |
Ejemplares similares
-
Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies
por: Russo, Emma E., et al.
Publicado: (2023) -
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
por: Calipari, Erin S., et al.
Publicado: (2013) -
Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones
por: Kasture, Ameya, et al.
Publicado: (2016) -
Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters
por: Solis, Ernesto, et al.
Publicado: (2016) -
Behavioral Effects of a Potential Novel TAAR1 Antagonist
por: Lam, Vincent M., et al.
Publicado: (2018)